Continuous midazolam infusion as treatment of status epilepticus

Roshan Lal Koul, Guru Raj Aithala, Alexander Chacko, Rajendra Joshi, Mussalem Seif Elbualy

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

In a tertiary referral centre, midazolam infusion was tried as treatment for 20 children with status epilepticus over a period of two years. The mean age of the children was 4.07 years. Twelve children with refractory status epilepticus had received intravenous or per rectal diazepam and intravenous phenytoin/phenobarbitone or both before midazolam was given (0.15 mg/kg bolus followed by 1-5 μg/kg/min infusion). Eight children required only midazolam to control the established status epilepticus. The seizures were controlled in 19 children. The mean time required for complete cessation of seizures was 0.9 hours. The mean infusion rate required was 2.0 μg/kg/min. All children had regained full consciousness by a mean of 5.1 hours after discontinuation of midazolam treatment. No metabolic derangement or compromise of vital functions was noted in any of the children. Midazolam infusion is thus an effective and safe therapeutic approach for the management of childhood status epilepticus.

Original languageEnglish
Pages (from-to)445-448
Number of pages4
JournalArchives of Disease in Childhood
Volume76
Issue number5
Publication statusPublished - 1997

Fingerprint

Status Epilepticus
Midazolam
Therapeutics
Seizures
Phenytoin
Phenobarbital
Diazepam
Consciousness
Tertiary Care Centers

Keywords

  • Midazolam
  • Refractory
  • Status epilepticus

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Koul, R. L., Aithala, G. R., Chacko, A., Joshi, R., & Elbualy, M. S. (1997). Continuous midazolam infusion as treatment of status epilepticus. Archives of Disease in Childhood, 76(5), 445-448.

Continuous midazolam infusion as treatment of status epilepticus. / Koul, Roshan Lal; Aithala, Guru Raj; Chacko, Alexander; Joshi, Rajendra; Elbualy, Mussalem Seif.

In: Archives of Disease in Childhood, Vol. 76, No. 5, 1997, p. 445-448.

Research output: Contribution to journalArticle

Koul, RL, Aithala, GR, Chacko, A, Joshi, R & Elbualy, MS 1997, 'Continuous midazolam infusion as treatment of status epilepticus', Archives of Disease in Childhood, vol. 76, no. 5, pp. 445-448.
Koul, Roshan Lal ; Aithala, Guru Raj ; Chacko, Alexander ; Joshi, Rajendra ; Elbualy, Mussalem Seif. / Continuous midazolam infusion as treatment of status epilepticus. In: Archives of Disease in Childhood. 1997 ; Vol. 76, No. 5. pp. 445-448.
@article{8e27e033fc4b4cc4a4d95a6a905b1eb7,
title = "Continuous midazolam infusion as treatment of status epilepticus",
abstract = "In a tertiary referral centre, midazolam infusion was tried as treatment for 20 children with status epilepticus over a period of two years. The mean age of the children was 4.07 years. Twelve children with refractory status epilepticus had received intravenous or per rectal diazepam and intravenous phenytoin/phenobarbitone or both before midazolam was given (0.15 mg/kg bolus followed by 1-5 μg/kg/min infusion). Eight children required only midazolam to control the established status epilepticus. The seizures were controlled in 19 children. The mean time required for complete cessation of seizures was 0.9 hours. The mean infusion rate required was 2.0 μg/kg/min. All children had regained full consciousness by a mean of 5.1 hours after discontinuation of midazolam treatment. No metabolic derangement or compromise of vital functions was noted in any of the children. Midazolam infusion is thus an effective and safe therapeutic approach for the management of childhood status epilepticus.",
keywords = "Midazolam, Refractory, Status epilepticus",
author = "Koul, {Roshan Lal} and Aithala, {Guru Raj} and Alexander Chacko and Rajendra Joshi and Elbualy, {Mussalem Seif}",
year = "1997",
language = "English",
volume = "76",
pages = "445--448",
journal = "Archives of Disease in Childhood",
issn = "1468-2044",
publisher = "BMJ Publishing Group",
number = "5",

}

TY - JOUR

T1 - Continuous midazolam infusion as treatment of status epilepticus

AU - Koul, Roshan Lal

AU - Aithala, Guru Raj

AU - Chacko, Alexander

AU - Joshi, Rajendra

AU - Elbualy, Mussalem Seif

PY - 1997

Y1 - 1997

N2 - In a tertiary referral centre, midazolam infusion was tried as treatment for 20 children with status epilepticus over a period of two years. The mean age of the children was 4.07 years. Twelve children with refractory status epilepticus had received intravenous or per rectal diazepam and intravenous phenytoin/phenobarbitone or both before midazolam was given (0.15 mg/kg bolus followed by 1-5 μg/kg/min infusion). Eight children required only midazolam to control the established status epilepticus. The seizures were controlled in 19 children. The mean time required for complete cessation of seizures was 0.9 hours. The mean infusion rate required was 2.0 μg/kg/min. All children had regained full consciousness by a mean of 5.1 hours after discontinuation of midazolam treatment. No metabolic derangement or compromise of vital functions was noted in any of the children. Midazolam infusion is thus an effective and safe therapeutic approach for the management of childhood status epilepticus.

AB - In a tertiary referral centre, midazolam infusion was tried as treatment for 20 children with status epilepticus over a period of two years. The mean age of the children was 4.07 years. Twelve children with refractory status epilepticus had received intravenous or per rectal diazepam and intravenous phenytoin/phenobarbitone or both before midazolam was given (0.15 mg/kg bolus followed by 1-5 μg/kg/min infusion). Eight children required only midazolam to control the established status epilepticus. The seizures were controlled in 19 children. The mean time required for complete cessation of seizures was 0.9 hours. The mean infusion rate required was 2.0 μg/kg/min. All children had regained full consciousness by a mean of 5.1 hours after discontinuation of midazolam treatment. No metabolic derangement or compromise of vital functions was noted in any of the children. Midazolam infusion is thus an effective and safe therapeutic approach for the management of childhood status epilepticus.

KW - Midazolam

KW - Refractory

KW - Status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=0030975570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030975570&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 445

EP - 448

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 1468-2044

IS - 5

ER -